RX

Prometheus Biosciences IncNASDAQ RXDX Stock Report

Last reporting period 31 Mar, 2023

Updated —

Last price

Market cap $B

9.559

Middle

Exchange

XNAS - Nasdaq

View Full Company Analysis

Prometheus Current ratio

23.3

Last period Current ratio


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of Prometheus ?

Prometheus`s Current ratio for the last twelve months ended 2023-03-31 is 23.3

View Full Company Analysis